A ROLE OF ARTIFICIAL INTELLIGENCE IN PARENTERAL FORMULATION: Parentral Applications of Artificial Intelligence
Bharathi Mohan · SPAST Abstracts · 2021
ROLE OF ARTIFICIAL INTELLIGENCE IN PARENTERAL FORMULATION R.Kamaraj1 M.Bharathi1* and K.Navyaja1 1 SRM College of Pharmacy, SRM University, Kattangulathur, Chennai. Artificial Intelligence [1] is defined as branch of computer science which deals about simulation of human intelligence processes by machines and refers to usage of automatic algorithms, machine vision and technologies in various sectors of to enhance R&D, from designing and identifying new molecules to target-based drug [2], validation and discoveries by emerging pharmaceutical field in several ways showing generation of new and better drugs. Artificial intelligence is an applied branch for pharmaceutical sector in development of various intelligent machines [3] and these novel technologies have several paradigm Al bodies such as neural networks, neuro-fuzzy logics and genetic algorithm which are developed to understand formulation design, structural design and process optimization in case of drug development for all means. As this intelligence has excess of handful applications it is utilized by pharma industries for various pharmaceutical product developments like sterile preparations such as parentrals, vaccines, seras and other blood products. The findings are intended to help raise awareness among populations impacted by the application of Artificial intelligence based technologies in the current pandemic[4] and in the future, to inform policy makers and health professionals who determine whether tools are arrayed during the current pandemic COVID -19 situations and in future public health disasters should be checked by implementing the present potentially stark consequences for marginalized and vulnerable populations (sorting and surveillance.) he scope of understanding artificial intelligence among developers and researchers is to support the fair, just, transparent, and accountable use of those AI applications in the future. Parenterals are preparations intended for injecting (or) administered directly into blood vessels, organs and tissues [5]. Parenteral route of drug administration generally includes intravenous (IV), subcutaneous (SC) and intramuscular (IM). This route of drug delivery offers an advantage for machine learning mainly for hospitalized and bedridden patients who cannot take medication orally (or) required for rapid onset of action. Developing (or) manufacturing of parenteral product is endowed challenge and complex process. Manual preparation of sterile injectable has always been considered a high-risk activity. So by using the computer algorithms, predictive analytics have been implemented in machine learning to process datas for the parenteral product sterility which is the key attribute for product safety and FDA proposed Current Good Manufacturing Practice (cGMP) regulations to establish minimum manufacturing standard. Therefore, pharmaceutical development is aimed to develop product with decided quality by using a defined manufacturing process. In recent years usage of sterile injectable preparations has been faced with a constant increase therefore the pharmaceutical industry has chosen to move towards automation of production which can reduce the risk of human factor errors by systematic and comprehensive high-dimensional datas produced at a high input with computerised algorithmic language and these are required for future generations. So based on this neural network, reduction of time is required for manufacturing preparations and to improve work Ergonomics. In fact automation allows to improve safety, reduce exposition to hazardous drugs also ensure a great repeatability and achieve traceability of each step in manufacturing process. As automation offers a safe alternative to the manual process. It was currently used in the production department to anticipate problems and find preventive measures in a formal approach. Conclusion: Automation process delivered a new perspective for the preparation of injectables to pharmaceutical industry. The interest of automation needs to adopt, to develop standardized preparations, to improve productivity and also able to capitalize on these emerging technologies.